China Oncology

Loading...

Welcome to China Oncology,

China Oncology

28 February 2022, Volume 32 Issue 2 Previous Issue Next Issue

Incidence and mortality of pancreatic cancer in Shanghai 2016 and epidemic trend analysis from 2002 to 2016

WU Mengyin, WU Chunxiao, PANG Yi, WANG Chunfang, GU Kai, GONG Yangming, BAO Pingping, SHI Liang, DOU Jianming, XIANG Yongmei, SHI Yan

2022, 32 (2): 97-105. doi: 10.19401/j.cnki.1007-3639.2022.02.001

Abstract ( 584) PDF (1780KB) ( 1177 ) HTML ( 1973 )

Basic research on photoacoustic sensing and imaging system for detecting sentinel lymph node in breast cancer

ZHAO Jiaxian, JIANG Daohuai, CONG Binbin, GAO Fei, WANG Yongsheng

2022, 32 (2): 106-117. doi: 10.19401/j.cnki.1007-3639.2022.02.002

Abstract ( 694) PDF (3320KB) ( 1720 ) HTML ( 2667 )

Progress in interventional therapy of extrahepatic cholangiocarcinoma

WANG Hongbo, YANG Yefa, GE Naijian

2022, 32 (2): 118-124. doi: 10.19401/j.cnki.1007-3639.2022.02.003

Abstract ( 709) PDF (1708KB) ( 1696 ) HTML ( 1341 )

Application of CT angiography in delayed DIEP flap breast reconstruction

XU Hua, LIU Ying, ZHANG Yi, WANG Tingliang, WANG Tao, HE Jinguang, LUO Jie, DONG Liping, WANG Hairong, DONG Jiasheng, XU Yuanbing

2022, 32 (2): 125-133. doi: 10.19401/j.cnki.1007-3639.2022.02.004

Abstract ( 579) PDF (2463KB) ( 848 ) HTML ( 57 )

The value of mpMRI combined with ^99mTc-PSMA SPECT/CT in the detection of significant residual prostate cancer after neoadjuvant androgen deprivation therapy

ZHOU Bingni, LIU Xiaohang, GU Bingxin, ZHOU Liangping, GU Yajia

2022, 32 (2): 134-141. doi: 10.19401/j.cnki.1007-3639.2022.02.005

Abstract ( 443) PDF (1827KB) ( 939 ) HTML ( 24 )

A study on influence of different signal peptides on anti-tumor effect of chimeric antigen receptor (CAR) T cells

LI Fan, ZHANG Qinxing, TONG Xiangwen, TIAN Gaohui, GU Lixing, XU Yao

2022, 32 (2): 142-151. doi: 10.19401/j.cnki.1007-3639.2022.02.006

Abstract ( 830) PDF (2158KB) ( 1765 ) HTML ( 70 )

Expression, prognostic value of CBX3 in lung adenocarcinoma and its effect on biological behavior of cancer cells

HOU Qinghua, ZHONG Yanfeng, LIU Linzhuang, WU Liusheng, LIU Jixian

2022, 32 (2): 152-160. doi: 10.19401/j.cnki.1007-3639.2022.02.007

Abstract ( 433) PDF (2604KB) ( 826 ) HTML ( 186 )

Clinical practice optimization exploration and future prospects of autologous hematopoietic stem cell transplantation for lymphoma

JIN Zhengming

2022, 32 (2): 161-171. doi: 10.19401/j.cnki.1007-3639.2022.02.008

Abstract ( 536) PDF (1627KB) ( 2327 ) HTML ( 721 )

New progress and prospect of breast cancer bone metastasis research from mechanism to clinic

WANG Jiahui, JIANG Linlan, SHEN Zan

2022, 32 (2): 172-176. doi: 10.19401/j.cnki.1007-3639.2022.02.009

Abstract ( 620) PDF (1804KB) ( 2165 ) HTML ( 1491 )

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer 2021 CACA-CBCS

Chinese Anti-Cancer Association, Committee of Breast Cancer Society

2022, 32 (2): 177-190. doi: 10.19401/j.cnki.1007-3639.2022.02.010

Abstract ( 1475) PDF (1835KB) ( 3323 ) HTML ( 6733 )

中国癌症杂志

Database Indexing

A Guide to the Core Journals of China
Chinese Science Citation Database (CSCD)
China National Knowledge Infrastructure (CNKI)
Chinese Sci-tech Paper and Citation Database (CSTPCD)
Outsanding S&T Journals of China (2020) (F5000)
World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
SCOPUS
EMBASE
DOAJ
Chemical Abstracts (CA)
Japan Science and Technology Database (JST)
The Western Pacific Region Index Medicus (WPRIM)
EBSCO
Index of Copernicus International (ICI)

Competent Authorities

　The Ministry of Education of the People’s Republic of China

Sponsored by

　Fudan University Shanghai Cancer Center

Edited by

　Editorial Board of China Oncology

Editor-in-Chief

　SHAO Zhimin

Honorary Editor-in-Chief

　TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

　Shanghai Ouyang Printing Co., Ltd.

WeChat